General MedicationsORALStandard

AMOXICILLIN AND CLAVULANATE POTASSIUM

AMOXICILLIN; CLAVULANATE POTASSIUM

Standard Dose

875MG;EQ 125MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 209991 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET;ORAL - 875MG;EQ 125MG BASE Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2023-09-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 209991 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET;ORAL - 875MG;EQ 125MG BASE Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2023-09-15 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.